Topic Tree

Our Reviews

Full list:

By subtopic:

Clinical care - by treatment category (357)
Alternative medicine/ Chinese herbal medicine (7)
Acupuncture for schizophrenia
Adjunctive Peony-Glycyrrhiza Decoction for antipsychotic-induced hyperprolactinemia (protocol stage)
Ayurvedic medicine for schizophrenia
Chinese herbal medicine for schizophrenia
Ginkgo biloba versus placebo for schizophrenia (protocol stage)
Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome (protocol stage)
Wendan decoction (Traditional Chinese medicine) for schizophrenia
Arts-based therapies (3)
Art therapy for schizophrenia or schizophrenia-like illnesses
Humour-based interventions for people with schizophrenia
Music therapy for people with schizophrenia and schizophrenia-like disorders
Assessment (2)
Outcome measures and needs assessment tools for schizophrenia and related disorders
Risk assessment for aggressive behaviour in schizophrenia (protocol stage)
Care packages & different (named) types of services (21)
'As required' medication regimens for seriously mentally ill people in hospital
Acceptance and Commitment Therapy for schizophrenia and related disorders (protocol stage)
Advance treatment directives for people with severe mental illness
Collaborative care approaches for people with severe mental illness
Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality
Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Crisis intervention for people with severe mental illnesses
Early intervention for psychosis
Interventions for prodromal stage of psychosis
Illness management and recovery programme for people with severe mental illness (protocol stage)
Implementation of treatment guidelines for specialist mental health care
Intensive case management for severe mental illness
Intermittent drug techniques for schizophrenia
Length of hospitalisation for people with severe mental illness
Life skills programmes for chronic mental illnesses
Mother and baby units for schizophrenia
Open general medical wards versus specialist psychiatric units for acute psychoses
Self-help and guided self-help interventions for schizophrenia and related disorders (protocol stage)
Social skills programmes for schizophrenia
Transitional discharge interventions for people with serious mental illness (protocol stage)
Twenty-four hour care for schizophrenia
ECT/TMS (5)
Electroconvulsive therapy for schizophrenia
Electroconvulsive therapy for treatment-resistant schizophrenia
Transcranial magnetic stimulation (TMS) for schizophrenia
Unilateral electroconvulsive therapy versus bilateral electroconvulsive therapy for schizophrenia (protocol stage)
Magnetic seizure therapy for people with schizophrenia
Educative approaches (26)
Health Professionals (8)
Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders
Educational games for mental health professionals
Implementation of treatment guidelines for specialist mental health care
Outcome measures and needs assessment tools for schizophrenia and related disorders
Post-incident debriefing for people with schizophrenia after coercive measures (protocol stage)
Risk assessment for aggressive behaviour in schizophrenia (protocol stage)
Screening programmes for helping mental health professionals to detect violent victimisation in people with severe mental illness (protocol stage)
Training to recognise the early signs of recurrence in schizophrenia
Consumers (18)
Behavioural family interventions versus structural family interventions for people with schizophrenia (protocol stage)
Family intervention (brief) for schizophrenia
Dietary advice for people with schizophrenia
Family intervention for schizophrenia
Family-based interventions versus standard care for people with schizophrenia (protocol stage)
General physical health advice for people with serious mental illness
HIV prevention advice for people with serious mental illness
Interventions to encourage uptake of cancer screening for people with severe mental illness
Oral health education (advice and training) for people with serious mental illness
Parenting interventions for people with schizophrenia or related serious mental illness
Information and communication technology in patient education and support for people with schizophrenia
Physical health care monitoring for people with serious mental illness
Psychoeducation for schizophrenia
Psychoeducation for siblings of people with severe mental illness
Psychoeducation for the parents of people with severe mental illness (protocol stage)
Self-help and guided self-help interventions for schizophrenia and related disorders (protocol stage)
Smoking cessation advice for people with serious mental illness
Psychoeducation (brief) for people with serious mental illness
Drugs (247)
Anti-convulsants / Convulsants (3)
Carbamazepine for schizophrenia
Lamotrigine for schizophrenia
Valproate for schizophrenia
Amino acids, hormones, enzymes, oils and nutritional agents (11)
Acetylcholinesterase inhibitors for schizophrenia
Adjunctive Peony-Glycyrrhiza Decoction for antipsychotic-induced hyperprolactinemia (protocol stage)
Antiglucocorticoid and related treatments for psychosis
Antioxidant treatments for schizophrenia
Estrogen for schizophrenia
Glutamatergic drugs for schizophrenia
Oestrogen (adjunct) versus placebo for women with schizophrenia (protocol stage)
Polyunsaturated fatty acid supplementation for schizophrenia
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Testosterone for schizophrenia
Vitamin E for antipsychotic-induced tardive dyskinesia
Anti-depressants (9)
Allopurinol and related drugs for schizophrenia (protocol stage)
Amphetamines for schizophrenia
Antidepressants for people with both schizophrenia and depression
Antidepressants for the negative symptoms of schizophrenia
Chlorpromazine versus lithium for people with schizophrenia (protocol stage)
Lithium for schizophrenia
Mirtazapine adjunct for people with schizophrenia
Mood stabilisers for schizoaffective disorder (protocol stage)
Selective noradrenaline reuptake inhibitors for schizophrenia
Anti-psychotics (182)
Acetophenazine (1)
Acetophenazine versus chlorpromazine for schizophrenia (protocol stage)
Amisulpiride (2)
Amisulpride for schizophrenia
Amisulpride versus other atypical antipsychotics for schizophrenia
Aripiprazole (13)
Aripiprazole for neuroleptic induced hyperprolactinaemia (protocol stage)
Aripiprazole for schizophrenia
Aripiprazole versus brexpiprazole for people with schizophrenia (protocol stage)
Aripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Aripiprazole versus haloperidol for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Aripiprazole versus other atypical antipsychotics for schizophrenia
Aripiprazole versus perphenazine for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Aripiprazole versus placebo for schizophrenia
Aripiprazole versus sulpiride for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Aripiprazole versus typical antipsychotic drugs for schizophrenia
Aripiprazole versus ziprasidone for schizophrenia (protocol stage)
Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation)
Long-acting aripiprazole (depot) versus placebo for schizophrenia (protocol stage)
Asenapine (2)
Asenapine versus other atypical antipsychotics for schizophrenia (protocol stage)
Asenapine versus placebo for schizophrenia
Benperidol (1)
Benperidol for schizophrenia
Bifeprunox (1)
Bifeprunox versus placebo for schizophrenia
Blonanserin (1)
Blonanserin versus risperidone for schizophrenia (protocol stage)
Brexpiprazole (2)
Aripiprazole versus brexpiprazole for people with schizophrenia (protocol stage)
Brexpiprazole versus placebo for people with schizophrenia (protocol stage)
Bromperidol (1)
Bromperidol decanoate (depot) for schizophrenia
Cariprazine (1)
Cariprazine versus placebo for schizophrenia (protocol stage)
Chlorpromazine (15)
Acetophenazine versus chlorpromazine for schizophrenia (protocol stage)
Aripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Cessation of medication for people with schizophrenia already stable on chlorpromazine
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
Chlorpromazine dose for people with schizophrenia
Chlorpromazine for psychosis induced aggression or agitation
Chlorpromazine versus lithium for people with schizophrenia (protocol stage)
Chlorpromazine versus metiapine for schizophrenia
Chlorpromazine versus penfluridol for schizophrenia
Chlorpromazine versus piperacetazine for schizophrenia
Chlorpromazine versus placebo for schizophrenia
Chlorpromazine versus reserpine for schizophrenia
Chlorpromazine versus thiothixene for people with schizophrenia (protocol stage)
Chlorpromazine versus clotiapine for schizophrenia
Haloperidol versus chlorpromazine for schizophrenia
Clotiapine (2)
Clotiapine for acute psychotic illnesses
Chlorpromazine versus clotiapine for schizophrenia
Clozapine (13)
Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia
Clozapine (generic versus branded) for people with schizophrenia (protocol stage)
Clozapine augmentation for treatment-resistant schizoaffective disorder (protocol stage)
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
Clozapine dose for schizophrenia
Clozapine for persistent aggressive behaviour or agitation in people with schizophrenia (protocol stage)
Clozapine versus olanzapine for people with schizophrenia (protocol stage)
Clozapine versus other atypical antipsychotics for schizophrenia
Clozapine versus quetiapine for people with schizophrenia (protocol stage)
Clozapine versus risperidone for people with schizophrenia (protocol stage)
Clozapine versus typical neuroleptic medication for schizophrenia
Pharmacological interventions for clozapine-induced hypersalivation
Newer atypical antipsychotic medication versus clozapine for schizophrenia
Droperidol (1)
Droperidol for psychosis-induced aggression or agitation
Flupenthixol (2)
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia
Fluphenazine (6)
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
Fluphenazine decanoate (depot) and enanthate for schizophrenia
Fluphenazine (dose) for people with schizophrenia (protocol stage)
Fluphenazine decanoate (timing of administration) for people with schizophrenia (protocol stage)
Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Fluphenazine (oral) versus placebo for schizophrenia
Fluspirilene (1)
Depot fluspirilene for schizophrenia
General (26)
Antipsychotic medication for childhood-onset schizophrenia
Antipsychotic medication for elderly people with schizophrenia
Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
Antipsychotics for people with persistent negative symptoms of schizophrenia (protocol stage)
Aripiprazole versus other atypical antipsychotics for schizophrenia
Aripiprazole versus typical antipsychotic drugs for schizophrenia
Asenapine versus other atypical antipsychotics for schizophrenia (protocol stage)
Atypical antipsychotics for people with both schizophrenia and depression
Benperidol for schizophrenia
Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
Clozapine versus other atypical antipsychotics for schizophrenia
Clozapine versus typical neuroleptic medication for schizophrenia
Antipsychotic combinations for schizophrenia
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
Lurasidone versus typical antipsychotics for schizophrenia (protocol stage)
Maintenance treatment with antipsychotic drugs for schizophrenia
Olanzapine for schizophrenia
Olanzapine versus other atypical antipsychotics for schizophrenia
Pharmacological interventions for acute and transient psychotic disorder (ATPD) (protocol stage)
Quetiapine for schizophrenia
Risperidone versus other atypical antipsychotics for schizophrenia
Risperidone versus typical antipsychotic medication for schizophrenia
Haloperidol (14)
Aripiprazole versus haloperidol for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Depot haloperidol decanoate for schizophrenia
Haloperidol (route of administration) for people with schizophrenia (protocol stage)
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)
Haloperidol dose for the acute phase of schizophrenia
Haloperidol for long-term aggression in psychosis
Haloperidol plus promethazine for psychosis-induced aggression
Haloperidol versus chlorpromazine for schizophrenia
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia
Haloperidol versus olanzapine for people with schizophrenia (protocol stage)
Haloperidol versus placebo for schizophrenia
Haloperidol versus risperidone for schizophrenia (protocol stage)
Haloperidol discontinuation for people with schizophrenia
Iloperidone (1)
Iloperidone versus placebo for schizophrenia (protocol stage)
Levomepromazine (1)
Levomepromazine for schizophrenia
Long-acting (10)
Bromperidol decanoate (depot) for schizophrenia
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders
Fluphenazine decanoate (depot) and enanthate for schizophrenia
Depot fluspirilene for schizophrenia
Depot haloperidol decanoate for schizophrenia
Depot perphenazine decanoate and enanthate for schizophrenia
Depot pipotiazine palmitate and undecylenate for schizophrenia
Long-acting aripiprazole (depot) versus placebo for schizophrenia (protocol stage)
Risperidone (depot) for schizophrenia
Olanzapine depot for schizophrenia (protocol stage)
Loxapine (1)
Loxapine for schizophrenia
Lurasidone (1)
Lurasidone versus typical antipsychotics for schizophrenia (protocol stage)
Methotrimeprazine (0)
Metiapine (1)
Chlorpromazine versus metiapine for schizophrenia
Modafinil (1)
Modafinil for people with schizophrenia or related disorders
Molindone (1)
Molindone for schizophrenia and severe mental illness
Olanzapine (8)
Clozapine versus olanzapine for people with schizophrenia (protocol stage)
Olanzapine depot for schizophrenia (protocol stage)
Olanzapine dose for people with schizophrenia (protocol stage)
Olanzapine for schizophrenia
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses
Olanzapine versus other atypical antipsychotics for schizophrenia
Olanzapine versus placebo for people with schizophrenia (protocol stage)
Risperidone versus olanzapine for schizophrenia
Palperidone (2)
Oral paliperidone for schizophrenia
Paliperidone palmitate for schizophrenia
Penfluridol (2)
Chlorpromazine versus penfluridol for schizophrenia
Penfluridol for schizophrenia
Perazine (1)
Perazine for schizophrenia
Pericyazine (1)
Pericyazine for schizophrenia
Perphenazine (4)
Aripiprazole versus perphenazine for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Depot perphenazine decanoate and enanthate for schizophrenia
Perphenazine for schizophrenia
Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Pimozide (1)
Pimozide for schizophrenia or related psychoses
Piperacetazine (1)
Chlorpromazine versus piperacetazine for schizophrenia
Pipotiazine (1)
Depot pipotiazine palmitate and undecylenate for schizophrenia
Quetiapine (5)
Clozapine versus quetiapine for people with schizophrenia (protocol stage)
Quetiapine dose for people with schizophrenia (protocol stage)
Quetiapine for schizophrenia
Quetiapine versus other atypical antipsychotics for schizophrenia
Quetiapine versus typical antipsychotic medications for schizophrenia
Risperidone (12)
Blonanserin versus risperidone for schizophrenia (protocol stage)
Clozapine versus risperidone for people with schizophrenia (protocol stage)
Haloperidol versus risperidone for schizophrenia (protocol stage)
Risperidone (depot) for schizophrenia
Risperidone (oral forms) for people with schizophrenia (protocol stage)
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation)
Risperidone dose for schizophrenia
Risperidone versus olanzapine for schizophrenia
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse
Risperidone versus other atypical antipsychotics for schizophrenia
Risperidone versus placebo for schizophrenia
Risperidone versus typical antipsychotic medication for schizophrenia
Sertindole (2)
Sertindole for schizophrenia
Sertindole versus other atypical antipsychotics for schizophrenia
Sulpiride (5)
Aripiprazole versus sulpiride for people with schizophrenia and schizophrenia-like psychoses (protocol stage)
Sulpiride for schizophrenia
Sulpiride versus other antipsychotics for schizophrenia (protocol stage)
Sulpiride versus placebo for schizophrenia
Sulpiride augmentation for schizophrenia
Thioridazine (1)
Thioridazine for schizophrenia
Thiothixene (1)
Chlorpromazine versus thiothixene for people with schizophrenia (protocol stage)
Trifluoperazine (3)
Trifluoperazine for schizophrenia
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Trifluoperazine versus placebo for schizophrenia
Ziprasidone (3)
Aripiprazole versus ziprasidone for schizophrenia (protocol stage)
Ziprasidone for schizophrenia and severe mental illness
Ziprasidone versus other atypical antipsychotics for schizophrenia
Zotepine (3)
Zotepine for schizophrenia
Zotepine versus other atypical antipsychotics for schizophrenia
Zotepine versus placebo for schizophrenia (protocol stage)
Zuclopenthixol (4)
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses
Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses
Zuclopenthixol dihydrochloride for schizophrenia
Zuclopenthixol versus placebo for schizophrenia
Anti-movement disorders (8)
Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia
Anticholinergics for neuroleptic-induced acute akathisia
Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia (protocol stage)
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
Calcium channel blockers for antipsychotic-induced tardive dyskinesia
Cholinergic medication for antipsychotic-induced tardive dyskinesia
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia
Anti-inflammatory (3)
Acetylsalicylic acid (aspirin) for schizophrenia
Celecoxib plus standard care for people with schizophrenia (protocol stage)
Haloperidol plus promethazine for psychosis-induced aggression
Calcium channel blockers (1)
Calcium channel blockers for antipsychotic-induced tardive dyskinesia
Anticholinergics, beta-blockers, benzodiazepines (11)
Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms (protocol stage)
Anticholinergic medication for antipsychotic-induced tardive dyskinesia
Anticholinergics (various) for neuroleptic-induced parkinsonism (protocol stage)
Anticholinergics for neuroleptic-induced acute akathisia
Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia (protocol stage)
Anticholinergics versus placebo for neuroleptic-induced parkinsonism (protocol stage)
Benzodiazepines for psychosis-induced aggression or agitation
Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses
Benzodiazepines for schizophrenia
Beta-blocker supplementation of standard drug treatment for schizophrenia
Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia
Central nervous system stimulants (4)
Amphetamines versus placebo for schizophrenia (protocol stage)
Atomoxetine for schizophrenia (protocol stage)
Cannabidiol for people with schizophrenia (protocol stage)
Nicotine for schizophrenia
Dose (12)
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
Chlorpromazine dose for people with schizophrenia
Clozapine dose for schizophrenia
Fluphenazine (dose) for people with schizophrenia (protocol stage)
Haloperidol dose for the acute phase of schizophrenia
Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia
Increasing antipsychotic dose for non response in schizophrenia
Olanzapine dose for people with schizophrenia (protocol stage)
Quetiapine dose for people with schizophrenia (protocol stage)
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Risperidone dose for schizophrenia
Lipid modifying agents (0)
Other substances (3)
Cannabidiol for people with schizophrenia (protocol stage)
Cannabis and schizophrenia
Cognitive behavioural therapy without medication for schizophrenia (protocol stage)
ICT (1)
Video games for people with schizophrenia
Physical activity (13)
Dance therapy for schizophrenia
Distraction techniques for schizophrenia
Drama therapy for schizophrenia or schizophrenia-like illnesses
Exercise therapy for schizophrenia
Horticultural therapy for schizophrenia
Intercessory prayer for the alleviation of ill health
Tai chi for schizophrenia (protocol stage)
Tai Chi plus standard care versus other exercise plus standard care for people with schizophrenia or related disorders (protocol stage)
Yoga as part of a package of care versus standard care for schizophrenia
Yoga as part of a package of care versus non-standard care for schizophrenia
Yoga for schizophrenia (protocol stage)
Yoga versus non-standard care for schizophrenia
Yoga versus standard care for schizophrenia
Psychological therapies (19)
Acceptance and Commitment Therapy for schizophrenia and related disorders (protocol stage)
Cognitive behavioural therapy (brief versus standard duration) for schizophrenia
Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia (protocol stage)
Cognitive behavioural therapy plus standard care for first episode psychosis (protocol stage)
Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia
Cognitive behavioural therapy without medication for schizophrenia (protocol stage)
Cognitive rehabilitation for people with schizophrenia and related conditions
Compliance therapy for schizophrenia
Computer-based Cognitive Remediation Therapy plus standard care versus standard care for people with schizophrenia or related disorders (protocol stage)
Cognitive behavioural therapy (group) for schizophrenia
Hypnosis for schizophrenia
Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness
Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia
Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia
Morita therapy for schizophrenia
Open Dialogue for psychosis or severe mental illness (protocol stage)
Parenting interventions for people with schizophrenia or related serious mental illness
Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Psychosocial interventions for people with both severe mental illness and substance misuse
Life and skills training (13)
Avatar Therapy for people with schizophrenia or related disorders
Communication skills training for mental health professionals working with people with severe mental illness
Distraction techniques for schizophrenia
Life skills programmes for chronic mental illnesses
Monetary incentives for schizophrenia
Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia
Peer support for people with schizophrenia or other serious mental illness
Problem solving skills for schizophrenia
Self-help and guided self-help interventions for schizophrenia and related disorders (protocol stage)
Social skills programmes for schizophrenia
Supported employment for adults with severe mental illness
Supportive therapy for schizophrenia
Token economy for schizophrenia
Clinical care - by specific additional problem (65)
Adverse effects/events (33)
Movement disorders (18)
Catatonia (1)
Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses
Parkinsonism (4)
Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms (protocol stage)
Anticholinergics (various) for neuroleptic-induced parkinsonism (protocol stage)
Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia (protocol stage)
Anticholinergics versus placebo for neuroleptic-induced parkinsonism (protocol stage)
Tardive Dyskinesia (13)
Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms (protocol stage)
Anticholinergic medication for antipsychotic-induced tardive dyskinesia
Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia (protocol stage)
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
Benzodiazepines for antipsychotic-induced tardive dyskinesia
Calcium channel blockers for antipsychotic-induced tardive dyskinesia
Cholinergic medication for antipsychotic-induced tardive dyskinesia
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Vesicular monoamine transporter inhibitors versus placebo for antipsychotic-induced tardive dyskinesia (protocol stage)
Vitamin E for antipsychotic-induced tardive dyskinesia
Polydipsia (1)
Pharmacological treatments for psychosis-related polydipsia
Other (7)
Adjunctive Peony-Glycyrrhiza Decoction for antipsychotic-induced hyperprolactinemia (protocol stage)
Aripiprazole for neuroleptic induced hyperprolactinaemia (protocol stage)
Beta-blocker supplementation of standard drug treatment for schizophrenia
Pharmacological treatment for antipsychotic-related constipation
Interventions for antipsychotic-induced amenorrhoea (protocol stage)
Pharmacological interventions for clozapine-induced hypersalivation
Pharmacological interventions for clozapine-induced sinus tachycardia
Weight gain (7)
Behavioural interventions for reducing weight gain in schizophrenia (protocol stage)
Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems
Pharmacological interventions for prevention of weight gain in people with schizophrenia
Interventions to reduce weight gain in schizophrenia
Pharmacological interventions for reducing weight gain in schizophrenia (protocol stage)
Pharmacological interventions for reduction of weight gain in people with schizophrenia (protocol stage)
Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome (protocol stage)
Psychosis-induced aggression or agitation (14)
Benzodiazepines for psychosis-induced aggression or agitation
Chlorpromazine for psychosis induced aggression or agitation
Clotiapine for acute psychotic illnesses
Containment strategies for people with serious mental illness
De-escalation techniques for psychosis-induced aggression or agitation
Droperidol for psychosis-induced aggression or agitation
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)
Haloperidol plus promethazine for psychosis-induced aggression
Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation)
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses
Post-incident debriefing for people with schizophrenia after coercive measures (protocol stage)
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation)
Seclusion and restraint for people with serious mental illnesses
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses
Compliance (3)
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders
Fluphenazine decanoate (depot) and enanthate for schizophrenia
Risperidone (depot) for schizophrenia
Persistent aggression (6)
Clozapine for persistent aggressive behaviour or agitation in people with schizophrenia (protocol stage)
Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia
Containment strategies for people with serious mental illness
Haloperidol for long-term aggression in psychosis
Post-incident debriefing for people with schizophrenia after coercive measures (protocol stage)
Seclusion and restraint for people with serious mental illnesses
Treatment resistant (9)
Antipsychotics for people with persistent negative symptoms of schizophrenia (protocol stage)
Clozapine augmentation for treatment-resistant schizoaffective disorder (protocol stage)
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
Electroconvulsive therapy for treatment-resistant schizophrenia
Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia
Increasing antipsychotic dose for non response in schizophrenia
Lamotrigine for schizophrenia
Non-clozapine antipsychotic combinations for treatment-resistant schizophrenia (protocol stage)
Switching antipsychotic for non response in schizophrenia (protocol stage)
Clinical care - by state/stage of illness (16)
Early (6)
Antipsychotic medication for early episode schizophrenia
Cognitive behavioural therapy plus standard care for first episode psychosis (protocol stage)
Early intervention for psychosis
Specialised early intervention teams (extended time) for recent-onset psychosis
Specialised early intervention teams for recent-onset psychosis
New generation antipsychotics for first episode schizophrenia
Acute (4)
Clotiapine for acute psychotic illnesses
Crisis intervention for people with severe mental illnesses
Open general medical wards versus specialist psychiatric units for acute psychoses
Training to recognise the early signs of recurrence in schizophrenia
Chronic (5)
Cessation of medication for people with schizophrenia already stable on chlorpromazine
Haloperidol for long-term aggression in psychosis
Life skills programmes for chronic mental illnesses
Maintenance treatment with antipsychotic drugs for schizophrenia
Preventing type 2 diabetes in adults with mental health conditions in low- and middle-income countries
Prodromal (1)
Interventions for prodromal stage of psychosis
Clinical care - by stage of life (8)
Adolescent (2)
Psychological interventions for psychosis in adolescents
Typical antipsychotics for psychosis in adolescents (protocol stage)
Children (1)
Antipsychotic medication for childhood-onset schizophrenia
Elderly (0)
Late onset (2)
Antipsychotic drug treatment for elderly people with late-onset schizophrenia
Antipsychotic medication for elderly people with schizophrenia
Child bearing age (3)
Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum
Mother and baby units for schizophrenia
Parenting interventions for people with schizophrenia or related serious mental illness
Clinical care - by specific diagnosis (27)
Acute and transient psychotic disorder (ATPD) (1)
Pharmacological interventions for acute and transient psychotic disorder (ATPD) (protocol stage)
Catatonic schizophrenia (2)
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses
Delusional disorder (2)
Treatments for delusional disorder
Treatments for primary delusional infestation
Dual diagnosis - affective disorder (1)
Antidepressants for people with both schizophrenia and depression
Dual diagnosis - learning disability (1)
Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
Dual diagnosis - substance abuse (1)
Psychosocial interventions for people with both severe mental illness and substance misuse
Psychosis (15)
Antiglucocorticoid and related treatments for psychosis
Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum
Benzodiazepines for psychosis-induced aggression or agitation
Chlorpromazine for psychosis induced aggression or agitation
Clotiapine for acute psychotic illnesses
Cognitive behavioural therapy without medication for schizophrenia (protocol stage)
De-escalation techniques for psychosis-induced aggression or agitation
Droperidol for psychosis-induced aggression or agitation
Early intervention for psychosis
Interventions for prodromal stage of psychosis
Haloperidol for long-term aggression in psychosis
Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation)
Open general medical wards versus specialist psychiatric units for acute psychoses
Psychological interventions for psychosis in adolescents
Typical antipsychotics for psychosis in adolescents (protocol stage)
Schizoaffective disorder (2)
Clozapine augmentation for treatment-resistant schizoaffective disorder (protocol stage)
Mood stabilisers for schizoaffective disorder (protocol stage)
Schizophreniform disorder (0)
Treatment resistant (2)
Antipsychotics for people with persistent negative symptoms of schizophrenia (protocol stage)
Electroconvulsive therapy for treatment-resistant schizophrenia
Diagnostic tests (4)
Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis
First rank symptoms for schizophrenia
Operational Criteria Checklist for Psychotic Illness and Affective Illness (OPCRIT+) for diagnosing schizophrenia in people with psychotic symptoms (protocol stage)
Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS) for diagnosing schizophrenia in children and adolescents with psychotic symptoms (protocol stage)

New and Updated (in the latest issue of the CLib):